3A8 [CMCC #11066]产品图

3A8 [CMCC #11066]

收藏
  • 询价
  • 2026年11月02日
    avatar
    15 年金牌会员
  • 企业认证

    • 详细信息
    • 技术资料
    • 免疫类型:

      IgG2b

    • 细胞形态:

      淋巴样

    • 生长状态:

      悬浮生长

    • 物种来源:

      小鼠

    • 是否是肿瘤细胞:

      0

    • 运输方式:

      冻存运输

    • ATCC Number:

      HB-12024™

    • 库存:

      大量

    Designations: 3A8 [CMCC #11066]
    Depositors:  Chiron Corp.
    Isotype: IgG2b
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
    Morphology: lymphoblast

    Source: Cell Type: hybridoma: B lymphocyte;
    Cellular Products: immunoglobulin; monoclonal antibody; against human CD40
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Comments: Animals were immunized with SF9 insect cells expressing recombinant human CD40.
    Spleen cells were fused with Sp2/0 myeloma cells.
    The antibody is capable of binding to human CD40 antigen located on the surface of human B cells.
    Propagation: ATCC complete growth medium: Iscove's modified Dulbecco's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate supplemented with 1% OPI (0.15 mg/ml oxaloacetate, 0.05 mg/ml pyruvate, 0.0082 mg/ml bovine insulin), 90%; heat-inactivated fetal bovine serum, 10%
    Temperature: 37.0°C
    Subculturing: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 X 10 exp5 viable cells/ml.
    Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
    Preservation: culture medium 95%; DMSO, 5%
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2005
    References: 40220: de Boer M, Conroy LB. Anti-CD40 monoclonal antibodies capable of blocking B-cell activation. US Patent 5,677,165 dated Oct 14 1997

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    ATCC细胞库
    2026年10月27日询价
    询价
    北京中源合聚生物科技有限公司
    2026年09月20日询价
    ¥1400
    上海盖宁生物科技有限公司
    2026年11月02日询价
    询价
    上海康朗生物科技有限公司
    2025年07月15日询价
    3A8 [CMCC #11066]
    询价